Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
82
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Safety
Conditions
Safety
Trial Timeline
Feb 1, 2005 โ Oct 1, 2006
NCT ID
NCT00461565About Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo
Sildenafil + Placebo + Vardenafil (Levitra, BAY38-9456) + Placebo is a approved stage product being developed by Bayer for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT00461565. Target conditions include Safety.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00461565 | Approved | Completed |
Competing Products
20 competing products in Safety